ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Randomized Clinical Trial |
Article Title |
Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Dorit Vedel Ankersen, Petra Weimers, Dorte Marker, Mette Bennedsen, Sanaz Saboori, Kristine Paridaens, Johan Burisch and Pia Munkholm |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Calpro AS |
- |
Ferring Pharmaceuticals |
- |
Crohn Colitis patient society Denmark |
- |
North Zealand University Hospital |
- |
|
Corresponding Author |
Pia Munkholm, MD, PhD, Chief Physician, Doctor, Doctor, Department of Gastroenterology, North Zealand University Hospital, Frederikssundsvej 30, Frederikssund 3600, Capital region, Denmark. pia.munkholm@regionh.dk |
Key Words |
Inflammatory bowel disease; Electronic health; Screening; Disease activity; ; |
Core Tip |
Involving patients with inflammatory bowel disease (IBD) in their disease by home-monitoring of disease activity, has been shown to bring patients with IBD significantly faster in remission relative to standard care, however, the optimal way to home-monitor patients with IBD for disease progression or relapse remains to be found. We randomized 102 patients with IBD to screen for disease activity either every third mo or whenever the patients felt a need for screening on the ibd.constant-care.com web-application for one year. We found that the two screening procedures were equally good in capturing a relapse and bringing about remission. |
Publish Date |
2019-10-28 11:23 |
Citation |
Ankersen DV, Weimers P, Marker D, Bennedsen M, Saboori S, Paridaens K, Burisch J, Munkholm P. Individualized home-monitoring of disease activity in adult patients with inflammatory bowel disease can be recommended in clinical practice: A randomized-clinical trial. World J Gastroenterol 2019; 25(40): 6158-6171 |
URL |
https://www.wjgnet.com/1007-9327/full/v25/i40/6158.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v25.i40.6158 |